Further analysis indicates the function of AMPK signaling in improving insulin sensitivity for diabetic patients’ treatment [14] Furthermore, clinical research on diabetes patients have demonstrated the involvement of AMPK signaling in the amelioration of diabetic sequelae such as nephropathy, brain disorder, and liver disease [15]. Here, PRKAA1 is linked to brain disorder.